Helius Book Value per Share vs Free Cash Flow per Share Analysis
| HSDT Stock | USD 5.82 0.35 5.67% |
Helius Medical financial indicator trend analysis is much more than just examining Helius Medical Techn latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Helius Medical Techn is a good investment. Please check the relationship between Helius Medical Book Value Per Share and its Free Cash Flow Per Share accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Helius Medical Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Book Value Per Share vs Free Cash Flow Per Share
Book Value per Share vs Free Cash Flow per Share Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Helius Medical Techn Book Value per Share account and Free Cash Flow per Share. At this time, the significance of the direction appears to have weak relationship.
The correlation between Helius Medical's Book Value per Share and Free Cash Flow per Share is 0.37. Overlapping area represents the amount of variation of Book Value per Share that can explain the historical movement of Free Cash Flow per Share in the same time period over historical financial statements of Helius Medical Technologies, assuming nothing else is changed. The correlation between historical values of Helius Medical's Book Value per Share and Free Cash Flow per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Book Value per Share of Helius Medical Technologies are associated (or correlated) with its Free Cash Flow per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow per Share has no effect on the direction of Book Value per Share i.e., Helius Medical's Book Value per Share and Free Cash Flow per Share go up and down completely randomly.
Correlation Coefficient | 0.37 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Free Cash Flow Per Share
The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.Most indicators from Helius Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Helius Medical Techn current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Helius Medical Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. At this time, Helius Medical's Selling General Administrative is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 0.02 in 2024, despite the fact that Enterprise Value is likely to grow to (225.7 K).
Helius Medical fundamental ratios Correlations
Click cells to compare fundamentals
Helius Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Helius Medical fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Common Stock Shares Outstanding | 15.1K | 24.0K | 49.1K | 269.9K | 607.9K | 577.5K | |
| Total Assets | 10.3M | 6.5M | 14.1M | 17.3M | 7.7M | 9.9M | |
| Total Current Liabilities | 3.8M | 2.4M | 2.7M | 2.0M | 1.9M | 1.8M | |
| Total Stockholder Equity | 5.8M | 3.9M | 11.3M | 8.2M | 2.4M | 2.9M | |
| Net Tangible Assets | 4.0M | 3.9M | 10.2M | 8.0M | 9.2M | 9.7M | |
| Net Debt | (4.8M) | (3.2M) | (11.0M) | (14.4M) | (5.1M) | (5.4M) | |
| Retained Earnings | (104.8M) | (118.9M) | (137.0M) | (151.1M) | (160.0M) | (152.0M) | |
| Accounts Payable | 1.7M | 747K | 1.1M | 627K | 531K | 504.5K | |
| Cash | 5.5M | 3.3M | 11.0M | 14.5M | 5.2M | 7.6M | |
| Cash And Short Term Investments | 5.5M | 3.3M | 11.0M | 14.5M | 5.2M | 7.7M | |
| Common Stock Total Equity | 52.2M | 26K | 31K | 1K | 900.0 | 855.0 | |
| Liabilities And Stockholders Equity | 10.3M | 6.5M | 14.1M | 17.3M | 7.7M | 9.9M | |
| Other Current Assets | 610K | 735K | 862K | 1.2M | 1.0M | 777.2K | |
| Total Liab | 4.5M | 2.7M | 2.8M | 9.1M | 5.3M | 7.1M | |
| Total Current Assets | 7.2M | 4.7M | 12.6M | 16.7M | 7.3M | 9.1M | |
| Short Term Debt | 172K | 59K | 3K | 54K | 45K | 42.8K | |
| Common Stock | 26K | 31K | 1K | 4K | 28K | 950.0 | |
| Other Current Liab | 1.5M | 1.3M | 1.4M | 1.3M | 1.3M | 1.2M | |
| Net Receivables | 574K | 230K | 251K | 343K | 637K | 401.2K | |
| Non Current Liabilities Total | 710K | 252K | 193K | 7.1M | 3.5M | 2.6M | |
| Capital Surpluse | 6.6M | 105.4M | 111.5M | 123.9M | 142.5M | 149.6M | |
| Other Stockholder Equity | 111.5M | 123.9M | 149.4M | 159.6M | 163.0M | 91.3M | |
| Accumulated Other Comprehensive Income | (902K) | (1.1M) | (1.1M) | (388K) | (673K) | (706.7K) | |
| Non Current Assets Total | 3.1M | 1.9M | 1.5M | 590K | 394K | 374.3K | |
| Property Plant And Equipment Net | 1.3M | 576K | 412K | 450K | 230K | 418.2K | |
| Net Invested Capital | 5.8M | 3.9M | 11.3M | 8.2M | 2.4M | 2.2M | |
| Property Plant And Equipment Gross | 1.3M | 576K | 412K | 450K | 589K | 631.4K | |
| Net Working Capital | 3.4M | 2.3M | 9.9M | 14.7M | 5.6M | 5.8M | |
| Property Plant Equipment | 1.3M | 486K | 412K | 450K | 517.5K | 612.2K | |
| Inventory | 598K | 389K | 476K | 589K | 457K | 531.9K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Helius Medical Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Helius Medical Techn information on this page should be used as a complementary analysis to other Helius Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Helius Stock analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Helius Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Helius Medical. If investors know Helius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Helius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (14.56) | Revenue Per Share 1.059 | Quarterly Revenue Growth (0.53) | Return On Assets (0.61) | Return On Equity (1.69) |
The market value of Helius Medical Techn is measured differently than its book value, which is the value of Helius that is recorded on the company's balance sheet. Investors also form their own opinion of Helius Medical's value that differs from its market value or its book value, called intrinsic value, which is Helius Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Helius Medical's market value can be influenced by many factors that don't directly affect Helius Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Helius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Helius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Helius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.